News and Events
Stay informed with the latest Sanofi investor news, financial results, earnings calls, and key event...
Publisher
France
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Stay informed with the latest Sanofi investor news, financial results, earnings calls, and key event...
Source route
Continue on sanofi.com
Leave the platform to read the original full article on the publisher site.
Source: Sanofi News
Scope: Industry
Related coverage
More related coverage
Shionogi Announces Corporate Reorganization and Personnel Reassignment (Effective April 1, 2026)
OSAKA, Japan, February 13, 2026 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO...
Mar.02.2026CorporateAnnouncement on Changes of the Board of Directors and Corporate Officers
Osaka, Japan, March 2, 2026 - Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President an...
Press releaseMar 29, 2026Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study140.7% of patients on Fabhalta demonstrated sustained reduction of protein in urine over two years1Fabhalta…
Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study 1 40.7% o...
AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting
Data highlights efficacy and safety of risankizumab in psoriatic disease, including high impact area...